Medpace Holdings Inc 01P
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €545.00
- Day Range
- €545.00–545.00
- 52-Week Range
- —–—
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 27.91M
- Market Cap
- $15.21B
- Volume/Avg
- — / 14
Key Statistics
- Price/Earnings (Normalized)
- 37.27
- Price/Sales
- 6.59
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 1.68%
Company Profile
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 6,500
- Website
- https://www.medpace.com
Competitors
Valuation
|
Metric
|
01P
|
IQV
|
FTRE
|
|---|---|---|---|
Price/Earnings (Normalized) | 37.27 | 20.84 | 155.89 |
Price/Book Value | 40.03 | 6.93 | 3.78 |
Price/Sales | 6.59 | 2.60 | 0.72 |
Price/Cash Flow | 28.98 | 16.89 | 37.10 |
Price/Earnings
01P
IQV
FTRE
Financial Strength
|
Metric
|
01P
|
IQV
|
FTRE
|
|---|---|---|---|
Quick Ratio | 0.66 | 0.62 | 0.85 |
Current Ratio | 0.73 | 0.71 | 0.96 |
Interest Coverage | — | 2.99 | 0.08 |
Quick Ratio
01P
IQV
FTRE
Profitability
|
Metric
|
01P
|
IQV
|
FTRE
|
|---|---|---|---|
Return on Assets (Normalized) | 26.82% | 7.22% | 2.15% |
Return on Equity (Normalized) | 130.01% | 34.41% | 10.56% |
Return on Invested Capital (Normalized) | 97.04% | 12.37% | 7.32% |
Return on Assets
01P
IQV
FTRE
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|^s!<&X? | LOCK|Hv | $243B | |||
| Danaher Corp
DHR
| LOCK|>J$sw<X | LOCK|#! | $155B | |||
| Agilent Technologies Inc
A
| LOCK|gVGJc#r? | LOCK|xQ | $48B | |||
| IQVIA Holdings Inc
IQV
| LOCK|!Kt?&R& | LOCK|R>&MP | $43B | |||
| Waters Corp
WAT
| LOCK|N^D?p!f | LOCK|%! | $43B | |||
| Illumina Inc
ILMN
| LOCK|<>JnR^ | LOCK|!!sQ | $42B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|r^X>KhT | LOCK|>y | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|>?h^FRZ | LOCK|Mhnn | $31B | |||
| Quest Diagnostics Inc
DGX
| LOCK|H@ZB<x? | LOCK|?b^$@ | $25B | |||
| Labcorp Holdings Inc
LH
| LOCK|?T^&^<L# | LOCK|&jD# | $25B |
United States